• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Sarepta Therapeutics

Parachute over a mountain in Switzerland
Biotech

Sarepta CEO to step down as DM1 hits home—Chutes & Ladders

Sarepta CEO to step down as DM1 hits close to home. Pops descends from Alkermes CEO seat. Former Novartis CMO Tsai saunters to Daiichi.
Darren Incorvaia , Zoey Becker , Will Maddox Feb 27, 2026 8:30am
sarepta building
Favicon Fierce Pharma

Sarepta CEO to retire, citing 'shocking and ironic twist of fate'

Feb 26, 2026 11:30am
Rotten tomato splat fruit

Fierce Biotech's Rotten Tomatoes of 2025

Dec 16, 2025 4:30am
Amazing landscapes of Appenzell with impressive rock formations and beautiful lakes

Dyne readies FDA push after DMD exon 51 med excels in trial

Dec 8, 2025 10:50am
Completing steps towards success checkmark on cubes symbolizing progress

Sarepta shares safety update on DM1 RNA med

Nov 24, 2025 4:00pm
sarepta building
Favicon Fierce Pharma

Sarepta, despite key trial flop, will seek full nod for DMD meds

Nov 4, 2025 7:56am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings